1Alder DD,Carson PL,Rubin JM,et al.Doppler ultrasound colorflow imaging in the study of breast cancer:Preliminary findings.Ultrasound Med Biol,1990,16(5):553-558.
2Lnlue k,Ozeki Y,Suganuma T.et al.Vascular endothelial growthfactor expression in primary esophageal squamous cell carcinoma.Association with angiogenesis and tumor progression[J].Cancer,1997,79(2):206-213.
4Giatromanolaki A, Koukourakis MI, Stathopoulos GP,et al. Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase,and of p53 protein expression in locally advanced gastric cancer. Oncol Res, 2000,12:33-41.
5Inoue K ,Ozeki Y ,Suganuma T ,et al. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer, 1997,79 : 206-213.
6Kobayashi M, Sugimoto T, Okabayashi T,et al. Localization of thymidine phosphorylase in breast cancer tissue. Medical Molecular Morphology, 2005,38 : 112-117.
7Nakajima Y, Gotanda T, Uchimiya H,et al. Inhibition of metastasis of tumor cells overexpressing thymidine phosphorylase by 2-deoxy-L-ribose. Cancer Research, 2004,64 : 1794-1801.
8Tsuchiya H, Kuwata K, Nagayama S, et al. Pharmacokinetic modeling of species dependent enhanced bioavailability of trifluorothymidine by thymidine phosphorylase inhibitor. Drug Metabolism & Pharmacokinetics,2004,19:206-215.
9Schwarz KQ ,Chen X,Bezante GP,et al. The Doppler kinetics of micro bubble echo contrast. Ultrasound Med Biol, 1996,22 (4):453-462.
